Pfizer-BioNTech’s COVID-19 vaccine is “safe” and “well tolerated” by children 5 to 11 years old and the right dosage triggers a “robust” immune response, according to study results announced Monday by Laboratories.
The two companies plan to submit this data to the authorities “as soon as possible”, according to a statement, which specifies that the immune reaction was “comparable” to that observed in 16 to 25 year olds who received a higher dose vaccine.
Further details will follow.
Watch video
Reference-feedproxy.google.com